Skip to main content
. 2018 May 21;11:320. doi: 10.1186/s13104-018-3420-8

Fig. 1.

Fig. 1

Clinical course of the patient. PSL prednisolone, TAC tacrolimus, MTX methotrexate, TCZ tocilizumab, iv. intravenous, sc. subcutaneous, IFX infliximab, CyA cyclosporine, CRP C-reactive protein, SSA serum amyloid A